2008
DOI: 10.1111/j.1399-0039.2008.01154.x
|View full text |Cite
|
Sign up to set email alerts
|

Development and clinical evaluation of a microarray for HLA‐A and ‐DRB1 genotyping

Abstract: Microarray technology makes high-throughput genotyping possible by permitting the simultaneous analysis of large sets of genes on a small reaction slide. Human leukocyte antigen (HLA) loci showing high polymorphisms are suitable targets for microarray. In this study, we developed a microarray kit with newly designed oligonucleotide probes for the genotyping of HLA-A and -DRB1. In total, 42 probes were designed to hybridize to polymorphic sites for HLA-A and 36 for HLA-DRB1. Asymmetric polymerase chain reaction… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2010
2010
2015
2015

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(9 citation statements)
references
References 19 publications
(27 reference statements)
0
9
0
Order By: Relevance
“…However, previous DNA-based methods are somewhat limited in that typing reactions are required for a large number of samples [16][17][18][19] . To resolve this problem, microarray technology has been applied for HLA genotyping of HLA-A 22 , HLA-B 20 , and HLA-DRB1 21,22 .…”
Section: Allele Assignmentmentioning
confidence: 99%
See 3 more Smart Citations
“…However, previous DNA-based methods are somewhat limited in that typing reactions are required for a large number of samples [16][17][18][19] . To resolve this problem, microarray technology has been applied for HLA genotyping of HLA-A 22 , HLA-B 20 , and HLA-DRB1 21,22 .…”
Section: Allele Assignmentmentioning
confidence: 99%
“…In this study, we utilized the asymmetric duplex PCR system based on previous studies [20][21][22] . In the PCR process, a lower concentration of forward primers than cy3-labeled reverse primers allowed for higher amplification of DNA targets than non-targets ( Figure 1A).…”
Section: Hybridization Experimentsmentioning
confidence: 99%
See 2 more Smart Citations
“…, 2005; Zhang et al. , 2006; Lee et al. , 2008), this technology has not found widespread acceptance in the histocompatibility and immunogenetics field largely due to the cost.…”
Section: Microarraysmentioning
confidence: 99%